Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma

Figure 2

Development of necroptosis-related miRNA (NRM) signature in TCGA training cohort. (a) LASSO Cox regression analysis of the 11 overall survival- (OS-) related NRMs. (b) Plot of 10-fold cross-validation error rates in the LASSO Cox regression analysis. (c) Hazard ratio of the six mRNAs identified. The principal component analysis (PCA) plot of the distribution between the high- and low-risk groups in (d) the training cohort, (e) the testing cohort, and (f) the whole TGCA cohort. Kaplan-Meier plot of has-miR-223-3p in (g) the training cohort, (h) the testing cohort, and (i) the whole TCGA cohort. Kaplan-Meier plot of has-miR-193-3p in (j) the training cohort, (k) the testing cohort, and (l) the whole TCGA cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)